1. Home
  2. CLDI vs EHGO Comparison

CLDI vs EHGO Comparison

Compare CLDI & EHGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDI
  • EHGO
  • Stock Information
  • Founded
  • CLDI 2014
  • EHGO 2015
  • Country
  • CLDI United States
  • EHGO China
  • Employees
  • CLDI N/A
  • EHGO N/A
  • Industry
  • CLDI Biotechnology: Biological Products (No Diagnostic Substances)
  • EHGO
  • Sector
  • CLDI Health Care
  • EHGO
  • Exchange
  • CLDI Nasdaq
  • EHGO NYSE
  • Market Cap
  • CLDI 20.2M
  • EHGO 23.0M
  • IPO Year
  • CLDI N/A
  • EHGO 2024
  • Fundamental
  • Price
  • CLDI $0.59
  • EHGO $0.79
  • Analyst Decision
  • CLDI
  • EHGO
  • Analyst Count
  • CLDI 0
  • EHGO 0
  • Target Price
  • CLDI N/A
  • EHGO N/A
  • AVG Volume (30 Days)
  • CLDI 51.3M
  • EHGO 3.3M
  • Earning Date
  • CLDI 08-12-2025
  • EHGO 08-12-2025
  • Dividend Yield
  • CLDI N/A
  • EHGO N/A
  • EPS Growth
  • CLDI N/A
  • EHGO N/A
  • EPS
  • CLDI N/A
  • EHGO N/A
  • Revenue
  • CLDI N/A
  • EHGO $15,393,105.00
  • Revenue This Year
  • CLDI N/A
  • EHGO N/A
  • Revenue Next Year
  • CLDI N/A
  • EHGO N/A
  • P/E Ratio
  • CLDI N/A
  • EHGO N/A
  • Revenue Growth
  • CLDI N/A
  • EHGO N/A
  • 52 Week Low
  • CLDI $0.20
  • EHGO $0.71
  • 52 Week High
  • CLDI $3.89
  • EHGO $5.50
  • Technical
  • Relative Strength Index (RSI)
  • CLDI 51.83
  • EHGO N/A
  • Support Level
  • CLDI $0.56
  • EHGO N/A
  • Resistance Level
  • CLDI $0.91
  • EHGO N/A
  • Average True Range (ATR)
  • CLDI 0.10
  • EHGO 0.00
  • MACD
  • CLDI -0.02
  • EHGO 0.00
  • Stochastic Oscillator
  • CLDI 27.34
  • EHGO 0.00

About CLDI Calidi Biotherapeutics Inc.

Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.

About EHGO ESHALLGO INC

Eshallgo Inc. focuses on two distinct market sectors: office supply sale and leasing, and after-sale maintenance and repair. It is an authorized distributor of brands of office equipment, including HP, Epson, Xerox, Sharp, Toshiba, Konica, Kyocera, and other brands.

Share on Social Networks: